Literature DB >> 7659571

Hemodynamics of idiopathic paroxysmal atrial fibrillation.

P Alboni1, S Scarfò, G Fucà, N Paparella, P Yannacopulu.   

Abstract

The hemodynamics of induced atrial fibrillation (AF) was investigated in 15 patients (ages 58 +/- 11 years) with paroxysmal AF presenting without organic heart disease or hypertension. A hemodynamic study was performed both during sinus rhythm and after the induction of AF. The mean heart rate increased from 73 +/- 11 to 128 +/- 18 beats/min (P < 0.001) after AF. Systolic and mean aortic pressures did not significantly change, and diastolic aortic pressure increased (78 +/- 11 vs 89 +/- 12 mmHg, P < 0.01). Left ventricular end-diastolic pressure decreased during AF (9 +/- 3 vs 6 +/- 2.6 mmHg, P < 0.005), whereas mean pulmonary wedge pressure increased (8 +/- 2 vs 12 +/- 4 mmHg, P < 0.001). Systolic pulmonary arterial pressure did not show significant variations, and there was a slight but statistically significant increase in the diastolic and mean pulmonary arterial pressures (P < 0.01). The right ventricular end-diastolic pressure decreased during AF (5.6 +/- 2 vs 3.8 +/- 2 mmHg, P < 0.01), whereas mean right atrial pressure showed a trend toward an increase. Stroke volume markedly decreased (P < 0.001) while the cardiac index did not significantly change. Systemic vascular resistance, pulmonary arteriolar resistance, and the arteriovenous O2 difference showed no significant variations after the induction of AF. These results suggest that in subjects without organic heart disease, paroxysmal AF is well tolerated hemodynamically, and the rise in the atrial pressures during AF is not related to an increase in the ventricular end-diastolic pressure.

Entities:  

Mesh:

Year:  1995        PMID: 7659571     DOI: 10.1111/j.1540-8159.1995.tb04738.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

Review 1.  Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.

Authors:  Michiel Rienstra; Steven A Lubitz; Saagar Mahida; Jared W Magnani; João D Fontes; Moritz F Sinner; Isabelle C Van Gelder; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2012-06-12       Impact factor: 29.690

2.  Health-related quality of life relative to clinical outcomes in patients with atrial fibrillation treated with ventricular rate stabilisation pacing.

Authors:  M A M Stofmeel; N M van Hemel; J C Kelder; R Yee; R E Labonté; M Taborsky; D E Grobbee
Journal:  Neth Heart J       Date:  2006-03       Impact factor: 2.380

3.  Ablate and pace revisited: long term survival and predictors of permanent atrial fibrillation.

Authors:  A Queiroga; H J Marshall; M Clune; M D Gammage
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

4.  Symptoms in atrial fibrillation: why keep score?

Authors:  Calum A MacRae
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-06

5.  Neurohormonal Activation After Atrial Fibrillation Initiation in Patients Eligible for Catheter Ablation: A Randomized Controlled Study.

Authors:  Emmanouil Charitakis; Håkan Walfridsson; Eva Nylander; Urban Alehagen
Journal:  J Am Heart Assoc       Date:  2016-12-12       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.